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1. Introduction 
Cancer is now recognized in both humans and in other multicellular animals as arising from 
a number of different causes, including specialized viruses, radiation, chemicals, certain 
highly irritative parasites (inflammation) and a number of other factors, such as specific 
genetic defects present in individual humans and possibly in every member of a colony of 
specially bred animal models. Cancer from non genetic causes largely from environmental 
factors, of which chemicals have a disproportionate share, is believed to contribute nearly 
70% of all cancer cases. Chemical carcinogenesis originally derives from experimental 
induction of malignant skin tumor in mice with chemicals. Early studies indicated some 
agents such as polycyclic aromatic hydrocarbons (PAH) could cause cancer of the skin if 
they were painted on to mice in high doses. These early studies also showed that  the 
induction of cancer was dose dependent; in low dosage they would not cause cancer but 
would render the skin susceptible to developing cancer on exposure to another agent, 
which, on its own would not induce cancer.  
Thus at the dawn of the 20th century, it was recognized that chemicals cause cancer; though 
individual cancer causing molecules had not yet been identified, nor their cellular targets 
clearly known. It was however clearly understood that carcinogenesis, at the cellular level, 
was predominantly an irreversible process. Knowledge of the mechanisms by which 
chemicals cause cancer and the molecular changes that characterize tumor progression was 
lacking. The origin of the understanding that cancer had a cause was first pointed out by the 
Italian investigator, Ramazini in 1700. Seven and a half decades later, the British Surgeon, 
Percival Pott made the connection between exposure to soot, rich in hydrocarbons and 
scrotal cancer (Pott, 1775). It is now known that at the most fundamental level, cancer is 
caused by abnormal gene expression. This abnormal gene expression occurs through a 
number of mechanisms, including direct damage to the DNA, and inappropriate 
transcription and translation of cellular genes. The contribution of chemicals to the 
carcinogenic process is well known to have increased given the parallel between 
industrialization with associated increased chemical production and utilization and the 
prevalence of cancer.  
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Increasing use of chemicals, particularly in the industrializing developing countries (Pakin et 
al., 1993; Pearce et al., 1994) places new demands on these countries, as they have limited 
resources to adequately regulate exposure to chemicals. Majority of the chemicals cause 
mutation in DNA among others. The consequences of increased exposure to  chemicals, risk of 
cancer, early detection of chemical-induced neoplastic changes and the prominent  role of 
biomedical engineering is poorly recognized generally and particularly in the developing 
countries where chemical carcinogenesis is believed to be currently more prevalent (Huff and 
Rall,1992). Cancer is classically viewed as the result of series of mutations, including 
dominantly acting oncogenes and recessively acting tumor- suppressor genes. Each mutation 
leads to the selective overgrowth of a monoclonal population of tumor cells, and each 
significant tumor property (invasiveness, metastasis and drug resistance) is accounted for by 
such mutation (figure 1).  The seminal observation that carcinogenesis is a multistage process 
helps to explain why some chemical carcinogens lack apparently important properties 
exhibited by others.  Such agents may act as promoters on tissues that have been previously 
initiated or have the ability to produce naturally occurring tumors without treatment. 
 
 
Fig. 1. Stages of the carcinogenic process 
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DNA-reactive Activation-independent Nitrogen mustards, chlorambucil 
Alkylating agents 
Epoxides: ethylene oxide 
Activation-dependent  Aliphatic halides: vinyl chloride 
Aromatic amines: monocyclic-o-toludine; polycyclic-4-
aminobiphenyl, benzidine 
Nitroaromatic compounds: 1-nitropyrene, 3-nitrofluoranthene 
Heterocyclic amines: 2-amino-3-methylimidazo [4,5-
b]pyridine(Ph1P) 
Aminoazo dyes: dimethylaminoazobenzene 
Polycyclic aromatic hydrocarbons: benzo(a)pyrene 
Substituted polycyclic aromatic hydrocarbons: 3-
methlycholanthrene 
N-nitroso compounds: dialkyl-dimethylnitrosamine, 
diethylnitrosamine; cyclic- 
N-nitrosonornicotine (NNK), nitrosomorphaline triazines, 
hydrazines, 
azoxymethane, methylazoxymethanol, benzene 
Mycotoxins: aflatoxin B1, aflatoxin G1 
Plant products: pyrrolizidine alkaloids, aristolochic acid, cycasin 
Pharmaceuticals: cyclophosphamide, phenacetin, tamoxifen 
Epigenetic Promoter  Liver enzyme-inducer type hepatocarcinogens: chlordane, DDT, 
pentachlorophenol, phenobarbital, polybrominated biphenyls, 
polychlorinated biphenyls 
Kidney: nitrilotriacetic acid  
Bladder: sodium saccharin 
Forestomach-butylated hydroxyanisole 
Endocrine-modifier Hormones: estrogens-17-estradiol; catechol estrogens-4-hydroxy-
estradiol, 2-hydroxyestradiol 
Estrogen agonists: 17-ethinyl estradiol, diethylstillbestrol (DES) 
Prolactin inducers: chloro-s-triazines-atrazine 
Antiandrogens: finasteride, vinclozolin 
Antithyroid thyroid tumor enhancers 
Thyroperoxidase inhibitors: amitrole, sulfamethazine 
Thyroid hormone conjugation enhancers: phenobarbital, 
Gastrin-elevating inducers of gastric neuroendocrine and glandular 
tumors: lansoprazole,omeprazole, pantoprazole 
Immunosuppressor Cyclosporin 
Purine analogs 
Cytotoxin Mouse forestomach toxicants: propionic acid, diallyl phthalate, 
ethyl acrylate 
Rat nasal toxicants: chloracetanilide herbicides 
Rat renal toxicants: potassium bromate, nitrilotriacetic acid 
Male rat kidney _2u-globulin nephropathy inducers: D-limonene, 
 p-dichlorobenzene 
Peroxisome proliferator Hypolipidemic fibrates: ciprofibrate, clofibrate, gemfibrozil 
Phthalates: di(2-ethylhexyl)phthalate(DEHP), di(isononyl)phthalate 
Lactofen 
Minerals and     Minerals: asbestos 
Metals      Metals: arsenic, beryllium, cadmium, chromium (IV), nickel, silica 
Unclassified     Acrylamide, acrylonitrile, dioxane 
 
 
Table 1. Classification of chemicals with carcinogenic activity 
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Foulds (1969) suggested that cancer development consisted of three, rather than two 
processes: (1) initiation, or the conversion of normal cells to a potentially precancerous form 
(2) promotion, or the expansion of the clones of initiated cells to form tumors; and (3) 
progression, or the development of tumors to increasing levels of malignancy. The original 
view was based on Foulds’ wealth of experience with both clinical and experimental cancer. 
It has however, been expanded greatly since it was first propounded by Foulds (1982). Other 
investigators have also made significant contributions to the understanding of the process of 
carcinogenesis by suggesting that there are two major cell-based processes essential to the 
formation of tumors (Ames and Gold, 1981).The first, or initiating stage, is due to mutation; 
alteration of the DNA of the affected cell through permanent modification of the DNA. 
These mutations take place at specific locations on the DNA, referred to as oncogenes and 
tumor suppressor genes, if these individual cells are to serve as precursors of cancer (Willis, 
1960; Klein and Klein, 1984). This area remains intensely investigated in the last couple of 
decades. What is perhaps worthy of note is that while the activation of an oncogene requires 
mutation at a specific single base (arrangement of the amines making up the DNA) pair on 
the DNA template, inhibition of a tumor suppressor gene may be achieved by a much wider 
range of damaging interactions.  
In current research, emphasis is laid on the identification of the genes that are involved in 
the mutation and subsequent molecular events. The failure in the control mechanisms 
regulating the expression of and response to tissue growth factors is of considerable interest 
in chemical carcinogenesis. This contributes to the risk of chemical carcinogenesis and is in 
turn attributable to a number of factors that will be discussed subsequently. A critical 
process in carcinogenesis is promotion. This involves cellular proliferation, which involves 
the division of cells to form two unusually identical cells. This may increase the number of 
both “normal” and neoplastic mutated or preneoplastic cells, enhancing the chance of a 
tumor being expressed in a clinically observable form. Surprisingly, such increased levels of 
cellular proliferation may not be apparent in normal cells of a particular tissue but may 
occur only in pretumor cells thus making early detection difficult. Tumors are well known 
to increase in their degree of malignancy with time, a process named “progression” by 
Foulds. Cohen and Elwein (1991) have suggested that progression is the result of a cascade 
of further critical mutations in the neoplastic cell population followed by further cell 
proliferation to increase the number of genetically altered cells and the chance of their 
forming an increasingly malignant, clinically apparent cancer.  
2. Summary of stages of chemical carcinogenesis 
Studies indicate that three stages of chemical carcinogenesis can be defined; initiation, 
promotion and progression as briefly alluded previously. 
Initiation: This is concerned with the induction of genetic changes in cells, leading to 
genome instability. This can be accentuated by micronutrient deficiency disorders. The 
nature of the initial changes is still incompletely elucidated (Satoh, 1988)  
Promotion: This largely involves the induction or commencement of cell proliferation. In 
this phase of carcinogenesis a promoting agent or enabling microenvironment, brings about 
increased cell proliferation. This stage is very important as it is reversible if the promoting 
agents or risk factor(s) are withdrawn. Probably also, if some genome stabilizing 
micronutrients are abundant. This stage has been exploited considerably for both 
therapeutic and chemopreventive measures that are in part dependent on micronutrients. 
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Progression: If cell proliferation is sustained then initiated cells acquire secondary genetic 
abnormalities in oncogenes which first lead to dysregulation and finally to autonomous 
growth characteristic of cancer. The ultimate end-point of progression is development of 
invasive neoplasm.  
While many environmental agents can be considered to be chemical carcinogens; some act 
as both initiators and promoter (complete carcinogens). The understanding of molecular 
aspects of chemical carcinogenesis has lead to development of the concept of 
chemoprevention (anticarcinogenesis). This process proposes strategies for intervention at 
the phase of malignancy using drugs or natural or synthetic agents to reverse or halt the 
evolution of carcinogenesis which is dependent on recognition of risk factors and early 
detection. 
2.1 Brief history of chemical carcinogenesis 
The history of chemical carcinogenesis is punctuated by key epidemiologic observations and 
animal experiments that identified cancer-causing chemicals and that led to increasingly 
insightful experiments to establish molecular mechanisms and to reduction of human 
exposure to chemicals. In 1914, Boveri (1914) made key observations of chromosomal 
changes, including aneuploidy. His analysis of mitosis in frog cells and his extrapolation to 
human cancer is an early example of a basic research finding generating an important 
hypothesis (the somatic mutation hypothesis). The first experimental induction of cancer in 
rabbits exposed to coal tar was performed in Japan by Yamagiwa and Ichikawa (1918) and 
was a confirmation of Pott's epidemiologic observation of scrotal cancer in chimney sweeps 
in the previous century (Potts, 1775). Owing to the fact that coal tar is a complex mixture of 
chemicals, a search for specific chemical carcinogens was undertaken. British chemists, 
including Kennaway (1930), took on this challenge and identified polycyclic aromatic 
hydrocarbons (PAHs), such as, benzopyrene, which was shown to be carcinogenic in mouse 
skin by Cook and his colleagues in 1933. The fact that benzopyrene and many other 
carcinogens were polyaromatic hydrocarbons lead the Millers (1947) to postulate and verify 
that many chemical carcinogens required activation to electrophiles (electron seeking 
moieties) to form covalent adducts with cellular macromolecules. This in turn prompted 
Conney and the Millers (1956) to identify microsomal enzymes (P450s) that activated many 
drugs and chemical carcinogens. 
3. Cell regulatory mechanisms: The cell cycle 
Carcinogenesis, or the sequence of events leading to cancer, is a multistep process involving 
both intrinsic and extrinsic factors. In the normal tissue, there are numerous regulatory signals 
that instruct cells when to replicate and when to die. In a cancer cell these regulatory 
mechanisms become disabled and the cell is allowed to grow and replicate unchecked. Thus at 
the most fundamental level cancer is caused by abnormal gene expression. This abnormal gene 
expression occurs through a number of mechanisms including direct damage to the DNA, and 
inappropriate transcription and translation of cellular genes. Carcinogenesis has been 
demonstrated abundantly to be induced or at least caused by exposure to certain types of 
chemicals (carcinogens). The mechanisms are elaborated on subsequently. The cell cycle plays 
an important role in this regard. It is concerned with the processes that govern the life and 
death of cells and through transient delay in G0 phase or outright apoptosis (programmed cell 
death) might be able to prevent damage in the DNA of a cell that may proceed to 
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carcinogenesis. In the normal cell, replication of the DNA and cell division is stimulated by the 
presence of growth factors that bind receptors at the cytoplasmic membrane and initiate a 
cascade of intracellular signals. Once these signals reach the nucleus they induce transcription 
of a complex array of genes producing proteins that mediate progression of the cell cycle 
culminating in mitosis or cell division. One remarkable contribution of biomedical engineering 
is the introduction of flow cytometer equipment which enable stages of the cell cycle to be 
followed and disorders or disruptions there of detected. 
The cell cycle is conventionally divided into four (4) phases, although there is the subsidiary 
G0 phase. The duration of each of these phases varies depending on factors such as cell type 
and localized conditions within a given tissue (microenvironment). At the end of mitosis 
(M) daughter cells enter gap 1 (G1) phase. 
 
 
Fig. 2. Schematic representation of Cell Cycle. 
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If conditions are favourable cells enter the synthetic (S) phase of the cycle where the entire 
genome is replicated during DNA synthesis. Following ‘S’ phase, cells enter the gap 2 (G2) 
phase before proceeding through mitosis again. A critical phase boundary exists early in the 
G1 phase called the restriction point. This is the point at which the cell must decide to either 
enter the cell cycle once more or to secondly  move into a state of quiescence; G0 phase.  
Once committed to this pathway, the cell can either remain in this state of replicative 
quiescence until it receives a signal to divide again. Alternatively the cell can proceed down 
a path that leads either to terminal differentiation or to apoptosis. Movement of a cell 
through the cell cycle is regulated by an enormously complex array of proteins.  
 
The proteins include: 
• Cyclins 
• Cyclin dependent kinases (CDKs) 
 
• Cyclin activating kinases (CAKs) 
 
• CDK inhibitory proteins. 
 
 
Binding of an appropriate growth factor at the cell surface starts a signaling cascade that ultimately 
leads to the expression of the G1 phase cyclins. It is important to remark that in normal cells, external 
stimuli (factors) such as growth factors are absolutely needed for the cell to proceed beyond the 
restriction point. Beyond this point, the cell is committed to DNA replication and cell division. 
Interference with the normal signal transduction pathway by chemical carcinogens, the mechanism 
notwithstanding can transform a cell into a state of proliferation that is not regulated by normal
physiological controls (carcinogenesis). This basically is broadly the molecular basis of carcinogenesis. 
 
Table 2. Proteins Controlling the Cell Cycle. 
It is note worthy that all phases of the cell cycle are regulated by the micronutrient zinc. 
Thus zinc deficiency common in many developing countries (WHO, 2002; Ames, 2010) can 
be risk factors in chemical carcinogenesis. Ho et al (2003) have elegantly demonstrated this 
in their studies. This is an area where biomedical engineering has contributed significant in 
the last five or more decades by the production of flame absorption spectrophotometers 
(FAAS) and later the graphite furnace (carbon rod) (GFAAS). This was followed by 
inductively coupled plasma mass spectrometer which allows for simultaneous multi 
element analysis. These equipment have exquisite sensitivities which enable the status of 
zinc and many other micronutrients to be detected and indirectly play a preventive role; 
reducing risk of cancer. 
4. Molecular biology and chemical carcinogenesis 
The discovery of DNA as the genetic material by Avery, MacLeod, and McCarthy (1944) and 
the description of the structure of DNA by Watson and Crick (1953) indicated that DNA was 
the cellular target for activated chemical carcinogens and that mutations (alterations in the 
sequence of bases making up amino acids) were key to understanding mechanisms of 
cancer. This led to defining the structure of the principal adducts in DNA (complexes of 
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DNA and a carcinogen or its metabolite) by benzo (a) pyrene (Carrel et al., 1997) and 
aflatoxin B1 (Croy et al., 1978). The concepts developed in investigating mechanisms of 
chemical carcinogenesis also led to discoveries that are relevant to other human conditions 
in addition to cancer, including atherosclerosis, cirrhosis, and aging. The fact that genetic 
changes in individual cancer cells are essentially irreversible and that malignant changes are 
transmitted from one generation of cells to another strongly points to DNA as the critical 
cellular target modified by environmental chemicals. DNA damage by chemicals occurs 
randomly; the phenotypes of associated carcinogenic changes are determined by selection. 
 Epidemiologic studies from all over the world have identified environmental and 
occupational chemicals as potential carcinogens. The most definitive epidemiologic studies 
have been those in which a small group is exposed to a tremendously large amount of a 
specific chemical, such as aniline dyes. The table below (table 3) lists some of the fairly well 
characterized chemicals sites where they have induced cancer. 
 
Carcinogens Site of cancer 
Chemical mixtures  Soots, tars, oils 
Cigarette smoke  
Skin, lungs 
Lungs 
Industrial chemicals Benzidine 
Nickel compound 
Arsenic 
Vinyl choride  
Urinary bladder 
Lungs, nasal sinuses 
Skin, Lungs 
Liver 
Drugs Mustard gas  
Phenacetin 
Lungs 
Renal pelvis  
Naturally occuring 
compounds  
Cyclomates 
Nitroso compounds  
Bladder 
Oesophagus, Liver, Kidney, stomach  
Table 3. List of Chemical Carcinogens. 
5. Mechanisms of chemical carcinogenesis  
As part of daily existence, DNA frequently sustains damage. If unrepaired, this can lead to 
mutations that replicate resulting in abnormal and cancerous development. Some biological 
mechanisms usually inhibit this process. An enzyme 8-oxoguanine DNA glycosylase 
(OGG1) among others repairs DNA by excising damaged nitrogen bases constituting the 
DNA. DNA damage may occur through exposure to chemicals present in cigarette smoke, 
ionizing radiation and oxidative stress, which can be induced by a number of chemicals 
such as cadmium and the polycyclic aromatic hydrocarbons. The levels of OGG1 can thus be 
used to predict an individual’s risk of developing cancer.  
At least four fundamentally different mechanisms of cancer induction by chemicals have been 
identified. These may lead to cancer as individual processes or on occasion, the same agent 
may exert its effects through two or more processes to lead to tumor formation. The 
importance of the mutation/proliferation approach to the development of cancer lies in its 
ability to encompass each of these mechanisms within a single frame work.  This as has been 
demonstrated (Clayson, 2001), means that if we can measure changes in mutation and 
proliferation frequencies, due to a specific carcinogen, there may be no need to elucidate the 
detailed mechanism of carcinogenesis for every chemical carcinogen before attempting  to 
calculate accurately the risk it may carry for exposed human subjects. This requires exquisite 
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and very sensitive instruments, and appears to be one challenge to specialists in biomedical 
engineering. Fortunately by the wide range of flow cytometry and mass spectrometry based 
techniques, the field of biomedical engineering appears to be rising to the challenge. It needs 
not be emphasized that a great deal of thought and effort will be required if mutation rates and 
proliferation in specific cell types are to be measured in humans by non-invasiveness. 
A number of chemical carcinogens now appear to exert their primary effect on the mutational 
part of the carcinogenic process, while some others seem to be relatively devoid of the ability 
to interact with DNA and appear to work mainly through a mechanism of induction of cellular 
proliferation. Mutation on the other hand appears to be induced by chemical carcinogens by at 
least two major modes.  The modes involve direct interaction with the DNA through the 
formation of highly reactive, positively charged entities known as “electrophiles”  This entity 
is capable of reacting chemically with many different cellular constituents, including the 
genetic material, DNA (Miller et al, 1961). The adducts formed with DNA the interaction 
products of such carcinogen-derived electrophiles with DNA, are not regarded as genetic 
lesions in their own right. They only represent the first stage in the formation of a mutational 
event. The adducts may be effectively repaired by the DNA repair enzyme system found in 
the cell nucleus as earlier indicated. In the alternative, if they are not repaired they may affect 
important sites on the DNA and consequently die, or if the DNA replicates while they are still 
present, may lead to mutations through base-mispairing or other errors, that is culminating in 
true genetic lesions.  This has been broadly illustrated by the figure below (figure 3). 
 
 
Fig. 3. Overview of genotoxic and non-genotoxic effects of carcinogens. 
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If the induced mutations occur at one or a relatively few critical sites on the DNA, then the 
cells may be converted from a “normal” to a preneoplastic state.  Chemically-induced 
mutations are not limited to critical genes, different pretumor cells may demonstrate a 
variety of different growth potentials due to the range of altered  ” non-critical” genes, thus 
enabling those cells with most favourable properties to transform most rapidly to  clinically 
apparent tumours. Alternatively, the carcinogens may act indirectly through the formation 
of reactive oxygen species or nitrogen radicals, some types of which are also highly reactive 
with macromolecules such as DNA. The process of raised cellular proliferation is also multi-
factorial in its genesis. It may arise from, for instance, direct hormone-like stimulation of 
specific cell types, from perturbation of tissue processes that lead to a balance between cell 
proliferation and cell death (apoptosis), it may alternatively arise from massive cell-killing 
or cytotoxicity followed by proliferative regeneration to maintain the physiological 
functioning of the affected tissues. A yet further way by which excess, tumor-inducing 
cellular division may be induced is that exhibited by the urinary bladder. Oyasu and his 
colleagues (1981) and in his subsequent studies (1995) showed by using heterotopical 
transplant rat bladder technique that urine by itself, but not water can induce proliferation. 
The mechanism by which this happens is not quite clear.  
It was however conceived that urine contained epithelial growth factors that stimulate cell 
division and that such factors would penetrate the epithelium should it be injured by the 
presence of a foreign agent in the bladder. A fourth type of mechanism of carcinogenesis 
may arise from the ability of the agent to form a complex with a specific protein. This 
complex (ligand-protein) may have the property of altering the expression of specific and 
important region in the DNA. There is the emerging but incompletely understood 
involvement of epigenetics; alteration in the genetic processes not involving DNA base 
sequence. Many epimutagens have already been identified and a number of existing 
chemicals such as cadmium are also known to act through this pathway. 
6. The environment and cancer 
Cancers caused by environmental agents frequently occur in tissues with the greatest 
surface of exposure to the agents: lung, gastrointestinal tract, and skin. Recently, the study 
of chemical carcinogenesis has merged with studies on the molecular changes in cancer 
cells, thus generating biological markers to assess altered metabolic pathways and providing 
new targets for therapy. Although these are exciting areas, they may be peripheral to 
attacking the primary causes of the most common human cancers. As more and more 
mutations are catalogued in cancer cells and more and more changes in transcription 
regulation, it becomes increasingly apparent that we need to understand what generates 
these changes. The fact that chemicals cause random changes in our genome immediately 
implies that our efforts need to be directed to quantifying these changes, reducing exposure, 
and developing approaches to chemoprevention (Extensively reviewed by Pereira, 1997).  
7. Mechanism of oxidative stress and DNA damage due to micronutrient 
deficiency 
Micronutrients are referred to as nutrients required in very small amounts that do not have 
calorific values but are extremely important for the maintenance of health. They comprise 
the vitamins and trace elements that regulate vital metabolic and molecular pathways and 
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processes. Some of them play very vital roles in DNA and RNA metabolism either as 
coenzymes or cofactors involved in their metabolism or as components of systems 
intimately interacting with these molecular regulators. The micronutrients are basically 
supplied in the diet or may be taken as supplements. Very few of them are synthesized 
endogenously enough to meet physiological requirements hence they are mostly essential.   
Based on public data emanating from the Healthy People 2010 Project, it has been estimated 
that about 80% of colon and prostate cancers, may be influenced by diet, nutrition, and life 
style. It has been proposed that DNA damage induced by dietary micronutrient deficiency 
accounts for about 33% of preventable cancers (Ames, 2001; Ames and Wakimoto, 2002). 
Owing to the fact that micronutrient deficiencies can induce DNA damage in a manner 
similar to those induced by ionizing radiation and reactive oxygen species (ROS), it has been 
suggested that oxidative stress and the associated DNA breaks are critical targets for 
nutritional control of carcinogenesis (Cheng, 2009) and perhaps a marker for early detection. 
When DNA lesions are left unrepaired they can promote accumulation of mutations that 
facilitate the process of carcinogenesis. Micronutrients may act directly on the genome to 
prevent mutations, or indirectly as enzyme cofactors in cellular processes that modulate 
transformation (Hanahan and Weinberg, 2000; Sjoblom et al., 2006). By yet incompletely 
defined mechanisms, micronutrients at levels higher than nutritional requirements may also 
activate DNA damage response or senescence, which are processes that are recognised to 
eliminate cancer cells or limit the progression of precancerous cells (Gorgoulis et al., 2005; 
Bartkova et al., 2005, 2006). The essential microminerals copper, iron, selenium and zinc play 
important roles in genome stability. In particular, these microminerals have significant 
impact on oxidative DNA damage and the corresponding repair pathways. 
Micronutrient intakes below recommended levels are known to be unusually widespread in 
poor countries, though also some segments of the  population in economically advanced 
nations such as the United States, especially among the poor, children, adolescents (Anetor, 
2009; Ames, 2010). It has been hypothesised that two of the many insidious but measurable 
consequences of moderate micronutrient inadequacy are increased DNA damage (precursor 
of cancer) and mitochondria decay which can cause mutagenic oxidant release also involved 
in future carcinogenesis. Studies indicate that sensitive assays targeted at these end points 
have a high probability of detecting changes in individuals with micronutrient 
deficiencies(Ames, 2010) This again appears instructive to scientists and technologists in the 
biomedical engineering field. 
8. Technology and chemical carcinogenesis 
Many technological advances have allowed conceptual ideas to be experimentally tested, 
including the sensitive detection of chemical carcinogens by high-pressure liquid 
chromatography (Esaka, et al., 2003) and mass spectrometry (Sigh and Farmer,2006), 
detection of DNA adducts by postlabeling (Randerath et al, 1981) and by specific antibodies 
(Poirier et al., 1977), transcriptional profiling by arrays ( Kallioniemi et al., 1992, Schena et 
al., 1995), and quantitation of mutagenicity of carcinogens using bacterial genetics (Ames et 
al., 1973). The testing of certain concepts in chemical carcinogenesis awaited the 
development of new technologies. For example, the concept of somatic mutations in cancer 
preceded by 40 years the establishment of DNA as the genetic material and by 67 years the 
development of DNA sequencing methods that directly showed clonal mutations in human 
cancer cells. Also, the mutator phenotype hypothesis formulated in 1974 has been only 
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recently experimentally verified. The list below shows some commonly employed analytical 
techniques requiring the attention of biomedical engineering and technology.  
Some analytical areas that may be particularly relevant in chemical carcinogenesis will 
include: 
- 32P-post labelling  
- Fluorescent-based techniques 
- Immunoassay-based techniques 
- Electrochemical detectors 
- Electron microscopy 
- High performance liquid chromatography/ Ultra high performance liquid 
chromatography 
- Comet (Single cell gel electrophoresis), imaging system 
- Mass spectrometry 
- Atomic absorption spectrophotometry (AAS) 
- Inductively coupled plasma- mass spectrometry (ICP-MS) 
- Advanced spectrophotometry 
- DNA microarray systems 
The latter is particularly promising as it enables the simultaneous measurement of 
transcription of thousands of genes using microchips containing thousands of probes of 
complementary DNA (cDNA) immobilized in predetermined array. But suffers the caveat of 
being very expensive especially for the developing countries that appear to be mostly in 
need of it currently. 
9. Early studies in chemical carcinogenesis and risk factors 
Early in the field of chemical carcinogenesis, investigators recognized that perturbation of 
the normal microenvironment by physical means, such as wounding of mouse skin or 
partial hepatectomy in rodents (Hennings and Boutwell, 1970; Fausto etal, 2006) or chemical 
agents, such as exposure of the mouse skin to certain phorbol esters (Berenblum, 1941), can 
drive clonal expansion of the initiated cells toward cancer. In the second stage, tumor 
promotion results in proliferation of the initiated cells to a greater extent than normal cells 
and enhances the probability of additional genetic damage, including endogenous 
mutations that accumulate in the expanding population. This classic view of two-stage 
carcinogenesis (Berenblum, 1941) has been conceptually important but also an 
oversimplification of the increasing understanding of the multiplicity of biological processes 
that are deregulated in cancer. In addition, an active debate continues on the relative 
contribution of procarcinogenic endogenous mechanisms—for example, free-radical–
induced DNA damage (Halliwell and Aruoma, 1991), DNA depurination (Lindahl and 
Nyberg, 1972), DNA polymerase infidelity (Loeb et al, 1974), and deamination of 5-
methylycytosine (Lindahl and Nyberg, 1974)—compared with exposure to exogenous 
environmental carcinogens (Ames et al, 1973).  
The enhancement of carcinogens by epigenetic mechanisms such as halogenated organic 
chemicals and phytoestrogens (Martin et al, 2007), as well as the extrapolation of results 
from animal bioassays for identifying carcinogens to human cancer risk assessment, are also 
difficult to quantify (Swenberg et al., 1998). As discussed below, this debate is not merely an 
academic event, in that societal and regulatory decisions critical to public health are at issue. 
The identification of chemical carcinogens in the environment and occupational settings 
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[benzo (a) pyrene and tobacco-specific nitrosamines in cigarette smoke, aflatoxin B1 (AFB1), 
residues from fossil fuel, vinyl chloride, pesticides and benzene] has led to regulations that 
have reduced the incidence of cancer. Further reduction or near total elimination may be 
achieved by sensitive instruments that enable early detection of up- stream changes that 
may culminate in cancer. This needless to say has heavy reliance on biomedical engineering. 
9.1 Risk factors and early detection: role for micronutrient deficiency and oxidative 
stress 
The risk of contracting cancer generally increases as the population grows older; this has 
been reported to be directly proportional to the number of years raised to the fourth power 
(Tolonen, 1990). This may be modified in the case of chemical carcinogenesis to include dose 
of chemicals or environmental agent to which the population is exposed and the 
stoichiometric bioavailability of protective factors such as the micronutrients. In animal 
models, such as the mice, the life-span of the models has been increased and cancer 
prevented by calorie restriction (reducing oxygen intermediates) and feeding them 
antioxidants. This suggests that excess calorie and antioxidant deficit (oxidative stress) are 
risk factors that may enhance the carcinogenic process. The natural dietary antioxidants, 
selenium, zinc, vitamins A, C, and E plus ┚-carotene protect against free radicals, lipid 
peroxidation (Tolonen, 1990) and thus the risk of chemical carcinogenesis. Ames (1983) has 
greatly emphasised the role of antioxidants largely derived from micronutrients as 
anticarcinogenesis. Vitamin C for instance is well known to counteract carcinogenic nitrous 
amine in the stomach. Urban population are more exposed to the risk of cancer than rural 
dwellers. This perhaps can be explained by the probability that the rural population is 
exposed to fewer carcinogens present in the environment.  
Additionally, there is the often neglected element of greater host resistance in that rural 
populations are more likely to consume diet replete with antioxidant micronutrients some of 
which will also enhance the immune system. This is important in that its contact with 
carcinogens either in the diet or environment is inevitable. Thus it may be possible for us to 
avoid the most prominent risk factors the most pragmatic option appears to be reinforcing 
host resistance .This may be enhanced by the use of biomarkers. Biomarkers are playing an 
increasing role in the assessment of human exposure to hazardous environmental pollutants 
or chemicals and in risk assessment to these compounds. Biomarkers may be applied at any 
stage in the toxicological process, ranging from measurement of the external dose as an 
indicator of exposure to determine altered structure and function of cells as a marker of 
effect- carcinogenesis.  Genetic carcinogens interact with nucleic acids to produce adducts, 
measurement of which is an indicator of the dose of active material which has reached the 
cells in question, termed biologically active dose (BAD), in the individual. This consequently 
incorporates the inter-individual variation in absorption, metabolism, and excretion of the 
compound which may affect risk assessment. 
10. DNA repair: Introduction 
To maintain the genomes of organisms, they have evolved a network of DNA repair 
pathways to excise altered residues from DNA. A major consideration is the relative 
contribution of environmental and endogenous DNA damage to carcinogenesis. DNA 
damage by environmental agents would have to be extensive and exceed that produced by 
normal endogenous reactive chemicals to be a major contributor to mutations and cancer. 
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This consideration underlines the difficulty in extrapolating risk of exposure to that which 
would occur at very low doses of carcinogens 
10.1 DNA repair and role of micronutrients as biomarkers of susceptibility to DNA 
damage 
Very many factors including nutritional factors have been shown to delay the carcinogenic 
process. Thus this can be exploited to reverse, delay or prevent the carcinogenic process. 
Maintenance of genome stability is of fundamental importance for counteracting 
carcinogenesis. Many human genome instability syndromes exhibit a predisposition to 
cancer. An increasing body of epidemiological evidence has suggested a link between 
nutrient status and risk of cancer. Populations in developing countries that are deficient in 
these protective micronutrients (WHO, 2002; Ames, 2010) and are increasingly exposed to 
chemicals owing to progressive or rapid industrialization are thus at increased risk (Anetor 
et al., 2008). Based on public data from the healthy people 2010 project, it is estimated that 
up to 80% of colon and prostate cancers may be influenced by diet, nutrition and life styles. 
As earlier indicated, it has been proposed that DNA damage induced by dietary 
micronutrient deficiency accounts for one-third of preventable cancers. Because 
micronutrient deficiencies can induce DNA damage in forms similar to those induced by 
ionizing radiation and reactive oxygen species (ROS), it has been suggested that oxidative 
stress and associated DNA breaks are critical targets for nutritional control of 
carcinogenesis. If left unrepaired, DNA lesions can promote accumulation of mutations that 
facilitate the process of carcinogenesis.  
Micronutrients may act directly on the genome to prevent mutations, or indirectly as 
enzyme cofactors in cellular processes that modulate transformation. Thus micronutrient 
status may serve as biomarkers of risk of carcinogenesis. For instance low selenium status is 
a biomarker of risk of many cancers including cancer of the prostate. This should be 
particularly appealing to industrializing developing countries. Human cells possess an 
armamentarium of mechanisms for DNA repair that counter the extensiveness of DNA 
damage caused both by endogenous and environmental chemicals. These mechanisms 
include base excision repair (BER) that removes products of alkylation and oxidation 
(Duncan et al, 1976; Roth and Samson, 2002; Gersson, 2002); nucleotide excision repair 
(NER) that excises oligonucleotide segments containing larger adducts (Setlow and Carrier, 
1963); mismatch repair that scans DNA immediately after polymerization for 
misincorporation by DNA polymerases (Modrich, 1991); and oxidative demethylation 
(Sedgwick, 2004), transcription-coupled repair (TCR) that preferentially repairs lesions that 
block transcription ( Hanawalt, 1994); double-strand break repair and recombination that 
avoids errors by copying the opposite DNA strand (Friedberg et al, 2005); as well as 
mechanisms for the repair of cross-links between strands ( Kuraoka et al, 2000; Zheng et al, 
2005) that yet need to be established. Micronutrients deficiency disorder may inhibit DNA 
repair, thus acting as risk factors. Determinations of the levels of micronutrients may 
therefore serve as biomarker of susceptibility to DNA damage using the various instruments 
provided by biomedical engineering. Micronutrient deficiency for instance is inversely 
correlated with the level of 8-hydrodeoxyguanosine (8-OHdG), a marker of oxidative DNA 
damage, which is mutagenic and has to be removed by protective enzymes such as the 
human oxo-guanine DNA glycosylase (hOGG1). 
Most DNA lesions are subject to repair by more than one pathway. As a result, only a 
minute fraction of DNA lesions which escapes correction are present at the time of DNA 
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replication and can direct the incorporation of noncomplementary nucleotides resulting in 
mutation. Unrepaired DNA lesions initiate mutagenesis by stalling DNA replication forks or 
are copied over by error-prone trans-lesion DNA polymerases (McCulloch and Kunkel, 
2008). Alternatively, incomplete DNA repair can result in the accumulation of mutations 
and mutagenic lesions, such as abasic sites (Loeb, 1985). Maintenance of genome stability is 
crucial for avoiding carcinogenesis. A number of human cancers display a range of 
chromosomal abnormalities; a characteristic now termed genome instability. The 
relationship between cancer and genome instability is well recognized, but the causes of 
genome instability in the evolution of human cancers is incompletely elucidated. The DNA 
damage response safeguards the integrity of the genome by detecting alterations, halting 
cell cycle progression and repairing damaged DNA. Zinc which plays a role in all the phases 
of cell cycle when deficient can be critical. (Anetor et al, 2008)  Cells with defective DNA 
damage responses are characterized by high level of genome instability (Cheng, 2009).  
It is known that in particular, cells in s-phase are vulnerable to agents, such as chemicals in 
the environment that cause DNA damage and induce DNA replication fork arrest. Since 
such events can adversely affect genomic stability, cells have evolved S-phase DNA 
response cascades, including checkpoint responses and DNA repair mechanisms, to fix 
DNA damage (Bartek et al., 2004). In response to DNA damage, check points are activated 
that coordinate DNA damage signaling, cell cycle arrest and DNA repair. Cells have 
developed elaborate systems to repair varieties of DNA damage. Abundant evidence has 
linked defects in DNA repair to carcinogenesis. As a way of avoiding mutagenic events, the 
DNA base excision repair (BER) pathway copes with oxidatively modified DNA (Xu et al., 
1997; Kungland et al., 1999), and nucleotide excision repair can deal with bulky DNA 
adducts including DNA cross-links (Cleaver, 2005). It is noteworthy that micronutrient 
deficiency significantly affects DNA damage repair. Zinc (Zn) deficiency is common in 
children and adults (WHO, 2002; Moshfegh et al., 2005). Human cell culture studies 
demonstrating severe Zn deficiency causes complex IV deficiency and the release of 
oxidants, resulting in significant oxidative DNA damage (Ho and Ames, 2002). Zinc 
deficiency has also been reported to cause chromosome breaks in rats (Bell et al, 1975) which 
has been associated with cancer in both animal models and humans (Fong et al., 2005).   
These reports strengthen the significant effect of micronutrient deficiency on DNA damage 
repair and by extrapolation on risk of carcinogenesis particularly chemical carcinogenesis in 
populations exposed to chemicals. Zinc deficiency in human cells has also been shown to 
inactivate Zn-containing proteins such as the tumor suppressor protein, p53 which plays a 
significant role in genome protection (Lane, 1992) and the DNA base excision repair 
enzyme,apyrimidinic/apurinic endonuclease, with a resulting synergistic effect on genetic 
damage (Ho and Ames, 2002;Ho Courtemanche and Ames, 2003). 
11. Integrative cell biology and chemical carcinogenesis 
Damage to DNA by chemical carcinogens activates checkpoint signaling pathways leading 
to cell cycle arrest and allows time for DNA repair processes (Sweasy et al, 2006). In the 
absence of repair, cells can use special DNA polymerases that copy past DNA adducts 
(Masutani et al., 2000) or undergo apoptosis by signaling the recruitment of immunologic 
and inflammatory host defense mechanisms. The demonstration that each 
methylcholanthrene-induced tumor has a unique antigenic signature provided one of the 
earliest glimpses into the stochastic nature of cellular responses to carcinogens. The 
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immunologic and inflammatory responses facilitate not only engulfment and clearance of 
damaged cells but also the resulting generation of reactive oxygen (Klebanoff, 1988) and 
nitrogen radicals (Ohshima and Batsch, 1994) that further damage cellular DNA.  
12. Chemical carcinogens and induced somatic mutations as biomarkers in 
molecular epidemiology 
Extensive experience of laboratory research in chemical carcinogenesis has provided a solid 
foundation for the analysis of chemical-specific macromolecular adducts and related 
somatic mutations in humans as biomarkers of carcinogen exposure. A paradigm for 
validating causal relationships between biomarkers of carcinogens exposure and a cancer 
risk biomarker is shown in a number of observations (Wogan et al, 2005). The metabolite, 
AFB1, a fungal toxin, is a prototypical example of an environmental chemical carcinogen 
that has been validated using this strategy. Benzo (a) pyrene, a polycyclic aromatic 
hydrocarbon 4-aminobiphenyl (Vineis and Pirastu, 1997), an aromatic amine dye, and 4-(N-
methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone, a tobacco-specific N-nitrosamine (Hetch, 
1999), are other key examples. The prevalence of Aflatoxin B1 in developing countries 
makes host resistance mechanism based on micronutrients of great import to reduction of 
risk of chemical carcinogenesis. 
13. Impact of new technologies or analytical techniques and biomedical 
engineering 
Recent advances in molecular methodologies are phenomenal, and they increasingly are 
being applied to understanding the interaction of chemical carcinogens with cellular 
constituents and metabolism. Cloning of DNA has facilitated the identification of specific 
genes mutated in human cancers. Chemical methods, including mass spectrometry, allow us 
to measure carcinogen alteration with unprecedented sensitivity and specificity, particularly 
the ultra high performance liquid chromatography (UHPLC) coupled to MS. Mass 
spectrometry is being coupled with many other site-specific techniques to study 
mutagenesis; to define how specific alterations in DNA produce cognate mutations. 
Sequencing of the human genome and the identification of DNA restriction enzymes opens 
up the field of molecular epidemiology, focusing in part on individual susceptibility to 
carcinogens. 
A very useful technique in cancer studies is the single cell protein electrophoresis (COMET 
ASSAY). This assay is the only direct method for the detection of DNA damage in cells. It is 
used in cancer research, in genotoxicity studies on environmental mutagens, and for 
screening compounds for cancer therapeutics. 
DNA microarray technology is a powerful tool that allows the activity of several genes to be 
monitored simultaneously. DNA microarray has been especially useful for detecting genes 
that respond to a specific chemical or physical signal in the same way. A DNA microarray or 
DNA chip consists of a solid surface, usually glass, to which DNA fragments are attached. 
The copies of each kind of fragments are attached to the glass surface at a specific site to   
regular pattern or array. DNA fragments attached to the chip act as probes that can 
hybridize with complimentary DNA or RNA molecules (targets) in solution.  DNA 
microarray technology has been used to study a wide variety of gene expression problems 
such as tissue specific, cell cycle specific, and tumor- specific gene activation and repression. 
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Once a similar pattern expression profile has been established for a group of genes, it seems 
reasonable to assume that the profile is at least partly caused by similar transcription 
regions. Therefore, if information is available about a regulatory region in one gene within 
this group, it may provide clues to the regulatory regions of other members of the group as 
well as to the protein factors that activate or inhibit gene expression. The initial stimulus 
may be a given carcinogen. Array technology facilitates analysis of carcinogen-induced 
alterations in the expression of both protein coding and noncoding genes. These are all areas 
where biomedical engineering is expected to play a pivotal role in risk identification and 
early detection. On the horizon are techniques that can measure single molecules of 
carcinogens in cells, random mutations in individual cells, analysis of the dynamics of how 
molecules exist and work, and bioinformatics and genetic maps to delineate complex 
interacting functional pathways in cells. Underlying this progress in understanding 
chemical carcinogenesis is a cascade of advances in molecular biology that makes it feasible 
to quantify DNA damage by chemical agents, mutations, and changes in gene expression.  
This calls for very intimate collaboration between biotechnology and biomedical engineering, 
a partnership that promises to be very rewarding in the fight against chemical carcinogenesis. 
Determining the structure of DNA, DNA sequencing, and the PCR revolutionized cell biology, 
including carcinogenesis. Advances in detection of DNA damage, including postlabeling of 
DNA (Randerath et al, 1981), immunoassays (Poirier et al, 1977) and mass spectrometry as 
earlier discussed (Singh and Farmer, 2006) have allowed the detection of a single altered base 
in 109 nucleotides using human nuclear DNA. This technology can be extended to analyze 
DNA or RNA in a single cell (Klein, 2005). Advances in cell biology, including array 
technology (Schena et al, 1995) and proteomics (Anderson et al, 1984; Aebersold et al, 1987), 
make it feasible to assess global changes in RNA and protein expression during 
carcinogenesis. Together, these technologies underlie systems biology, making it increasingly 
feasible to map biochemical pathways in cancer cells from DNA, to RNA, to proteins, to 
function. This again calls for greater involvement of the biomedical engineering field. 
The ultimate application of techniques of biomedical engineering in the field of chemical 
carcinogenesis holds great promise, but faces several formidable challenges requiring 
ingenuity in matching technology with a social obligation to ensure that those most affected 
can afford its dividend to combat the menace of chemical carcinogenesis. This calls for 
sensitive methods for the early detection. The complex interplay among these and the great 
promise they hold for human health, particularly in the rapidly industrializing developing 
countries has not been adequately addressed. This contribution largely sees this as needing to 
be addressed- carcinogenesis, integrating chemical exposure, nutritional; mainly micronutrient 
modulation and the yawning gap biomedical engineering should fill in non-invasive 
applications. Although the field of biomedical engineering as regards cancer studies is still 
relatively in its early stages and will be a long-term effort and the magnitude of the task far 
greater than the physical resources and intellectual capacity currently available, the challenge 
is to focus on sensitive, specific or selective, cost effective and efficient techniques with 
dereliction for resource poor rapidly industrializing developing countries that appear to bear a 
greater brunt of the increasing chemical exposure and attendant carcinogenic risk. 
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